Profil clinique et immunologique des patients infectés par le VIH dépistés à Cotonou, Bénin

Clinical and Immunological Characteristics in HIV-Infected Patients at the Treatment Initiation at the University Hospital of Parakou (Benin)

“…Apetse [3] reported similar results with a predominance of oral candidiasis (49.7%) followed by tuberculosis 11.30% and toxoplasmosis (11.20%). A similar situation exists with the results of Zannou [6] in which digestive candidiasis (53%) predominated followed by pneumonia (18%), tuberculosis (12%), undetermined pneumonitis (29%), prurigo (20%) zona (16%), cryptosporidiosis (4%), cerebral toxoplasmosis (3%) and Kaposi's disease (1%).…”

“…Zannou [6] and Kra [7] had also made the same remark. Whereas Shen et al [8] reported a male predominance.…”

“…In this study, the reasons for consultation were dominated by chronic diarrhea in 28.41% of the cases. The main reasons for coming reported by Déguénonvo [4] are long-term fever (83%), weight-loss (83%), cough [6] during the testing were: weight-loss (88%), fever (80%), cough (71%) and diarrhea (51%).…”

Characteristics and Follow-up of Newly Managed HIV-Infected Patients in the National Referral Center in Ouagadougou, Burkina Faso

“…The female predominance and the younger age of our patients are typical data of the epidemiology of HIV infection in Burkina Faso and West Africa. [1][2][3][4][5] Studies in Ouagadougou and Bobo-Dioulasso show that men have less recourse to health services, women are more concerned with screening and feel more vulnerable about the diagnosis, the motivations of men and women differ, and their experiences of screening and its consequences are different. 6 Early age at first sex among girls and the relative protection afforded by male circumcision are also factors that could explain the female predominance.…”

“…Symptomatic status of patients is also reported in other developing countries, where the majority of patients are in stage B and C of the CDC classification or 3 and 4 of the WHO classification. [3][4][5][11][12][13][14] Men were more clinically symptomatic than women (71% vs 57% in stages 3 and 4, P ¼ .03) without statistically significant immunologic difference. In Cotonou, a study found a higher frequency of severe immune deficiency in men than in women because men usually present for screening later than women.…”